In addition, the “Berlin patient,” an HIV+ individual who developed leukemia and was functionally cured of HIV by a transplant with bone marrow from a CCR5Δ32 homozygote given after leukemia chemotherapy, provided proof-of-principle that targeting CCR5 might be a cure strategy in HIV/AIDS. This evidence concerns the gene CCR5 and AIDS.